Opportunity cost in palliation of NSCLC
•
Median survival with inoperable NSCLC
Ø
PS 2 - 3 or mets:
120 days
Ø
Asymptomatic
§
No treatment; no toxicity; no loss of survival
Ø
Symptomatic
§
1 treatment for equivalent symptom control and
toxicity to longer treatment
§
BUT…will any patients live longer with 20Gy/39Gy